SDG 3. GOOD HEALTH & WELL-BEING BenevolentAI

BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies

October 14, 2021, by PR Newswire:

LONDON, Oct. 14, 2021 /PRNewswire/ — In a significant milestone for its (AI)-driven drug discovery platform, BenevolentAI has nominated a preclinical candidate for a novel ...

Read more on PR Newswire:


SDG 3. GOOD HEALTH & WELL-BEING Joanna Shields BenevolentAI

How AI could transform post-pandemic healthcare

January 26, 2021, by insider@insider.com (Chris Stokel Walker)

        Joanna Shields, the chief executive officer of BenevolentAI, an artificial intelligence-powered drug discovery startup. Astrid Stawiarz/Getty Images Joanna Shields is the ...

Read more on Business Insider